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Abstract
Introduction The aim of the study was to evaluate some of the
underlying pathomechanisms of hydroxyethylstarch (HES)
induced adverse effects on renal function using 24 porcine
kidneys in an isolated perfusion model over six hours.
Methods Infusion of either 10% HES 200/0.5, 6% HES 130/
0.42 or Ringer's lactate (RL) was performed to achieve an
haematocrit of 20% in eight kidneys from four animals per
group. Physiological and pathophysiological parameters were
determined (including N-acetyl-beta-aminoglucosidase as a
marker for lysosomal tubular damage). Histological
investigations and immunohistological stainings of the kidneys
were performed.
Results Initially after haemodilution, HES 130/0.42 and HES
200/0.5 reduced urine output compared with RL (P < 0.01).
After six hours, N-acetyl-beta-aminoglucosidase was
significantly higher in HES 200/0.5 (81 ± 23 U/L) compared
with HES 130/0.42 (38 ± 12 U/L) and RL (21 ± 13 U/L; P <
0.001). Osmotic nephrosis-like lesions (OL) of the tubuli were
present in all groups showing a significantly lower number of OL
in RL (1.1 ± 0.4; P = 0.002) compared with both HES groups
(HES 200/0.5 = 2.1 ± 0.6; HES 130/0.42 = 2.0 ± 0.5).
Macrophage infiltration was significantly higher in HES 200/0.5
compared with HES 130/0.42 (1.3 ± 1.0 vs. 0.2 ± 0.04; P =
0.044). There was a significant increase in interstitial cell
proliferation in the HES 200/0.5 group vs. HES 130/0.42 (18.0
± 6.9 vs. 6.5 ± 1.6; P = 0.006) with no significant difference in
RL (13.5 ± 4.0).
Conclusions We observed impaired diuresis and sodium
excretion by HES and identified renal interstitial proliferation,
macrophage infiltration and tubular damage as potential
pathological mechanisms of HES-induced adverse effects on
renal function using an isolated porcine renal perfusion model.
Furthermore, we demonstrated that 10% HES 200/0.5 had
more of a pro-inflammatory effect compared with 6% HES 130/
0.42 and caused more pronounced tubular damage than 6%
HES 130/0.42 and RL. OL were present in all groups, but to a
lesser degree after RL administration.
Introduction
Sepsis and septic shock are associated with both a relative
and an absolute intravascular volume deficit [1]. Thus, ade-
quate volume replacement to restore and maintain circulating
plasma volume appears to be fundamental to improve organ
perfusion and nutritive microcirculatory flow. It has been
shown that early goal-directed fluid resuscitation in patients
with severe sepsis and septic shock is associated with
improved outcome [2]. Recently updated international guide-
lines indicate that there is no solid evidence for preferring
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either colloids or crystalloids for fluid replacement in patients
with sepsis or septic shock [3]. Recommended goals are to
achieve and sustain a central venous pressure of at least 8
mmHg (≥12 mmHg if the patient is mechanically ventilated)
and to administer fluid challenges, initially 1 L of crystalloids or
up to 0.5 L of colloids in 30 minutes, for as long as key haemo-
dynamic parameters, such as arterial blood pressure and heart
rate, are improving in patients with signs of hypovolaemia. The
question of which type of solution should be used as volume
replacement remains controversial [4]. Hydroxyethylstarch
(HES) solutions are one group of volume replacement solu-
tions (VRS) that can be trialled in the haemodynamically unsta-
ble patient, and recent developments include the introduction
of new formulations and newly available HES products.
Adverse effects of HES administration on renal function have
spurred ongoing research into the pathological mechanisms.
Schortgen and colleagues showed HES to be an independent
risk factor for acute renal failure in severe sepsis [5]. The meth-
odology of this study has been questioned, although it was
randomised and controlled [6-8]. Recently, in a German mult-
icentre randomised controlled trial (efficacy of volume substi-
tution and insulin therapy in severe sepsis (VISEP) study) it
has been shown that the use of 10% HES 200/0.5 compared
with Ringer's lactate (RL) in patients with severe sepsis or sep-
tic shock is associated with an increased need for renal
replacement therapy [9]. In this study the cumulative dosage
of 10% HES200/0.5 was significantly correlated with the
need for renal replacement therapy.
Of note, the underlying pathomechanisms of the HES-induced
renal injury could not yet be identified. Indeed, a recent large
prospective observational study in over 3000 critically ill
patients showed that in those with ICU stays of more than 24
hours, sepsis, heart failure and haematological cancer were all
significantly associated with the need for dialysis or haemofil-
tration therapy, but volume replacement with HES was not
[10]. Comparing the result with the data of the VISEP study,
one important difference is the total amount of administered
HES. In the VISEP study patients received HES for up to 21
days with a median cumulative dose of 70.4 ml/kg (interquar-
tile range: 33.4 to 144.2 ml/kg), whereas in the observational
study the median total amount of HES per patient was lower
at 1000 ml (interquartile range: 500 to 2250 ml corresponding
to a cumulative dose of less than 15 ml/kg).
In the situation of kidney transplantation, osmotic nephrosis-
like histological lesions (OL) have been noticed retrospectively
in kidney transplant recipients when HES was used for fluid
resuscitation of donors who were brainstem dead [11]. Using
HES 200/0.62, a detrimental effect on initial graft function
could be demonstrated [12]. Histologically, OL were detected
in most of the specimens.
Given the lack of data, the aim of the study was to investigate
whether interstitial proliferation, macrophage infiltration and/or
tubular damage could be potential pathomechanisms of HES-
induced adverse effects on renal function using two different
HES solutions in comparison to a crystalloid solution (RL). We
selected 10% HES 200/0.5 because its negative impact on
renal function was shown in the VISEP study and 6% HES
130/0.42 is one of the currently used HES solutions.
Materials and methods
Female German landrace pigs (n = 12, mean weight = 44.0 ±
4.6 kg) were used and the principles of laboratory animal care
were followed, based on the guidelines of the local Animal
Care office. The study was approved by the local Animal Pro-
tection Committee and by the governmental Animal Care
Office (Thüringer Landesamt für Lebensmittelsicherheit und
Verbraucherschutz, Bad Langensalza, Germany). Animals
were fasted for 24 hours with water ad libitum before the
experiment.
Infusion solutions
Three different VRS were studied: one crystalloid and two dif-
ferent HES solutions. RL as a crystalloid solution (Sterofundin,
BBraun Melsungen, Germany) was compared with 10% HES
200/0.5 in 0.9% sodium chloride (NaCl; Hemohes 10%,
BBraun, Melsungen, Germany) and 6% HES 130/0.42 in
0.9% NaCl (Venofundin 6%, BBraun, Melsungen, Germany).
Kidney retrieval
Pigs were premedicated with ketamine (500 mg intramuscu-
larly) to allow placement of an intravenous catheter in an auric-
ular vein and to initiate pulse oximetry and continuous
echocardiography (ECG) monitoring. Anaesthesia was
induced by intravenous injection of propofol (2 to 3 mg/kg)
and sufentanil (3 μg/kg) until intubating conditions were
achieved. Pigs were orally intubated and placed in the supine
position. Anaesthesia was maintained with a continuous infu-
sion of propofol (20 to 35 mg/kg/hour). Controlled mode ven-
tilation was chosen to ventilate the animals with an inspiratory
oxygen fraction of 1.0, an inspiratory/expiratory ratio of 1:2 and
a respiratory rate of 16 breaths/minute. The tidal volume was
adjusted to maintain a partial pressure of arterial carbon diox-
ide (PaCO2) of 35 to 40 mmHg. The body core temperature
was kept above 37°C by using an infrared lamp and warmed
solutions.
Using sterile technique, the right external jugular vein and right
carotid artery were surgically exposed. For blood sampling, an
8.5 F introducer sheath was inserted into the right external jug-
ular vein and an arterial catheter for haemodynamic monitoring
was placed into the right carotid artery.
Accordingly to a predefined random list, animals were allo-
cated for fluid therapy with one of the three VRS. Thereafter,
haemodilution was performed in the animals using either 500Available online http://ccforum.com/content/13/1/R23
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mL of 10% HES 200/0.5 or 6% HES 130/0.42 solutions or
1000 mL of RL. Thereafter, 1 L of blood was collected by
autologous normovolaemic haemodilution into a sterile recep-
tacle containing 15,000 IU heparin and 5 mg verapamil. In all
animals, a midline laparotomy was performed using standard-
ised sterile surgical techniques and both kidneys were surgi-
cally removed 15 minutes after infusion of VRS and flushed
immediately with 250 ml saline at a temperature of 37°C and
a hydrostatic pressure of 100 cm.
Isolated organ perfusion
Immediately after preparation the kidneys were reperfused on
the isolated organ perfusion system (IOPS; Figure 1). The
IOPS was designed using commercially available clinical-
grade cardiopulmonary technology consisting of a centrifugal
blood pump (0–40-00; Stöckert, Munich, Germany), a heat
exchanger (ST II; Stöckert, Munich, Germany) and an oxygen-
ator (Polystan Safe Micro; Maquet Cardiopulmonary, Hirrlin-
gen, Germany). The gas flow was adjusted to achieve a partial
pressure of arterial oxygen (PaO2) of 200 mmHg and a paCO2
of 30 mmHg. The circuit hardware included a TS 410 flow
transducer (Transonic Systems Inc., Ithaka, NY, USA) and
pressure transducers (BBraun, Melsungen, Germany). The cir-
cuit was primed with isotonic saline. To the circuit, 400 ml
heparinised whole blood was added after priming and allowed
to circulate at a temperature of 37°C. For the control of the
haematocrit a continuous blood parameter monitoring system
(CDI 500; Terumo Cardiovascular Systems, Ann Arbor, Mi,
USA) was integrated in the IOPS.
Experimental protocol
After stabilisation, the kidneys were perfused with one of the
investigated VRS aimed at maintenance of a constant haema-
tocrit of 20%. If 10% HES 200/0.5 was used for haemodilu-
tion during kidney retrieval in vivo, we continued to use 10%
HES 200/0.5 for perfusion of the kidneys in the IOPS. The
same applied for 6% HES 130/0.42 and RL. Renal blood flow,
pressure and resistance were monitored continuously. Urine
output was recorded hourly. From urine specimen, N-acetyl-
beta-D-glucosamidase (beta-NAG; analysed by a spectropho-
tometric method; Hoffmann-La Roche, Basel, Switzerland),
which is a sensitive marker of lysosomal tubular damage, was
measured (normal range 0 to 7 U/L). Creatinine clearance was
measured as an estimate of glomerular filtration rate (ClCrea =
Ucrea × Uvol/Pcrea × duration of urine collection period; where
Ucrea = urine creatinine concentration; Uvol = urine volume dur-
ing the collection period; Pcrea = serum creatinine concentra-
tion). Colloid osmotic pressure (COP) was analysed using a
membrane colloid oncometer with a 20,000-Daltons semiper-
meable membrane (BMT 923; Delta-Pharma, Pfullingen, Ger-
many). Blood gas analyses and urine sodium analyses were
measured using a standard blood gas oximetry system (ABL
625; Radiometer, Copenhagen, Denmark) with a co-oximeter.
All of the above named parameters were determined every two
hours.
Histological analysis
Needle-core biopsies were taken after perfusion, fixed in 4%
formaldehyde and embedded in paraffin. Sections of 4 μm
were cut and stained with H&E, Periodic Acid-Schiff and a
fibrous tissue stain (Sirius red). Renal morphology was
assessed semiquantitatively using the following four criteria of
tubulointerstitial renal injury: acute tubular necrosis (dilation of
tubuli with flattening or loss of the tubular epithelium) intersti-
tial bleeding, interstitial inflammation and OL of the tubuli. KA,
blinded to the VRS groups, scored each variable using a sem-
iquantitative scoring system (0 to 4) for each criterion in 20
randomly sampled visual fields per animal: 0 (absent), 1 (0 to
25%), 2 (25 to 50%), 3 (50 to 75%) or 4 (more than 75%).
For further analysis immunohistochemisty was performed
using antibodies against proliferating nuclear antigen (PCNA)
for interstitial or glomerular cell proliferation and the marker for
macrophage infiltration ED-1. KA, blinded to the VRS groups,
assessed the number of positive cells per visual field in 20 ran-
domly sampled visual fields per animal (positive cells/visual
field (pc/vf)).
Statistical analysis
Data were analysed using SPSS 13.0 for Windows (SPSS
Inc., Chicago, IL, USA) and all results are presented as mean
± standard deviation. After verifying normal data distribution
Figure 1
Schematic diagram of the isolated renal perfusion system Schematic diagram of the isolated renal perfusion system.Critical Care    Vol 13 No 1    Hüter et al.
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(skewness < 1.5) [13], effects of infusion solution and time
were statistically analysed by analysis of variance (ANOVA) for
repeated measurements with Bonferroni's correction for multi-
ple comparisons (diuresis, sodium transport, ClCrea and beta-
NAG). All histological parameters were analysed using
ANOVA with Bonferroni's correction. For the significance level
of an alpha value of 0.05 an analysis of the prospective power
of the experimental design was performed. A three-fold
increase in beta-NAG between two groups was regarded as
important. A sample size of at least seven kidneys in each
group was necessary in order to achieve a power of 80%.
Results
All animals and kidneys were analysed. The groups were com-
parable in regards to the mean arterial pressure and renal
blood flow (Table 1). Overall, animals received 82.1 ± 24.5 ml/
kg RL (22.9 ± 2.3 ml/kg during preparation and 59.2 ± 22.2
ml/kg during isolated renal perfusion), 20.0 ± 1.2 ml/kg HES
200/0.5 (11.9 ± 0.7 ml/kg during preparation and 8.1 ± 0.5
ml/kg during isolated renal perfusion) or 33.0 ± 7.6 ml/kg HES
130/0.42 (10.9 ± 1.2 ml/kg during preparation and 22.1 ± 5.4
ml/kg during isolated renal perfusion). This resulted in 2.0 ±
0.04 g/kg hydoxyethylstarch in group HES 200/0.5 and 2.0 ±
0.2 g/kg hydoxyethylstarch in group HES 130/0.42 during the
whole experiment.
Functional parameters
The mean diuresis during the study period was significantly
higher over time in the RL group (16.2 ± 9.0 μl/minute/g) com-
pared with HES 130/0.42 (3.6 ± 2.4 μl/min/g) and HES 200/
0.5 (0.3 ± 0.5 μl/minute/g; P < 0.001; Table 2). Mean sodium
transport over time was significantly lower in the HES 130/
0.42 (-4.1 ± 0.8 mmol/minute/g) and HES 200/0.5 (-0.3 ± 0.2
mmol/minute/g) groups compared with RL (-13.9 ± 4.8 mmol/
minute/g; P < 0.01; Table 2). During the study period mean
Clcrea was significantly lower in the HES 200/0.5 group (0.01
± 0.01 ml/minute/g) compared with the RL group (0.37 ±
0.06 ml/minute/g) and the HES 130/0.42 group (0.26 ± 0.05
ml/minute/g; P < 0.001; Table 2). After six hours beta-NAG as
a marker of lysosomal tubular damage differed significantly in
the HES 200/0.5 group (81.8 ± 23.4 U/L) compared with the
HES 130/0.42 group (38.3 ± 11.8 U/L) and the RL group
(20.9 ± 13.4 U/L; Figure 2). COP was different between
groups; however, statistical significance between HES 200/
0.5 and HES 130/0.42 disappeared after six hours (24.8 ±
3.4 mmHg vs. 24.5 ± 3.7 mmHg, respectively; Figure 3).
Histological parameters
Histological examinations indicated that OL was present in all
groups; there was, however, a significant difference with RL
(1.1 ± 0.4) compared with HES 130/0.42 (2.0 ± 0.5) and
HES 200/0.5 (2.1 ± 0.6; P < 0.01; Table 3). Cell proliferation
(PCNA) in the HES 200/0.5 group (18.8 ± 7.1 pc/vf) was sig-
nificantly higher than in HES 130/0.42 (7.2 ± 1.7 pc/vf; P =
0.008). There was no significant difference between PCNA
and RL (14.1 ± 4.1 pc/vf). Comparison of interstitial and
glomerular proliferation revealed significantly more pro-
nounced interstitial cell proliferation: HES 200/0.5 (18.0 ± 6.9
pc/vf) vs. HES 130/0.42 (6.5 ± 1.6 pc/vf, P = 0.006). There
was no significant difference with RL (13.5 ± 4.0 pc/vf; Table
3, Figure 4). The number of interstitial macrophages (ED-1)
was significantly lower in the HES 130/0.42 group (0.2 ± 0.04
pc/vf) compared with the HES 200/0.5 group (1.3 ± 1.0 pc/
vf, P = 0.044). There was no significant difference with RL (0.4
± 0.3 pc/vf; Table 3, Figure 5). Using Periodic Acid-Schiff
stain no tubular atrophy was seen in any of the groups. On Sir-
ius red sections, there was no increase in interstitial fibrous tis-
sue content in all groups.
Discussion
In our study, directly after haemodilution both HES solutions
induced a significant decrease in diuresis, Clcrea and sodium
Table 1
Haemodynamic variables during isolated renal perfusion
Time (hours) 0 2 4 6
Blood flow
(ml/g organ weight)
HES 200/0.5 0.87 ± 0.15 0.92 ± 0.2 0.9 ± 0.24 0.98 ± 0.19
HES 130/0.42 0.86 ± 0.12 0.87 ± 0.09 0.86 ± 0.08 0.96 ± 0.07
RL 0.83 ± 0.18 0.94 ± 0.07 1.03 ± 0.19 0.98 ± 0.19
MAP (mmHg)
HES 200/0.5 69 ± 6 74 ± 6 79 ± 8 78 ± 10
HES 130/0.42 72 ± 9 77 ± 12 76 ± 9 81 ± 7
RL 77 ± 10c 69 ± 7a 73 ± 11 77 ± 9
Values are mean ± standard deviation. There were no statistical differences between groups.
HES = hydroxyethyl starch; MAP = mean arterial pressure; RL = Ringer's lactate.Available online http://ccforum.com/content/13/1/R23
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transport compared with RL. We identified interstitial macro-
phage infiltration indicating interstitial inflammation and tubular
damage as structural alterations which underlie the HES-
induced adverse effects on renal function using an isolated
porcine renal perfusion model. Furthermore, we demonstrated
that 10% HES 200/0.5 caused more interstitial macrophage
influx and tubular damage than 6% HES 130/0.42.
The issue of HES-induced effects on renal function continues
to be debated. Various investigations found vacuoles in vari-
ous human tissue specimens [14,15]. These HES-containing
vacuoles were called osmotic-like lesions. The OL were sug-
gested to explain the adverse renal effects of HES, although a
pathophysiological relationship between the vacuoles and
renal dysfunction was not shown. In the situation of kidney
transplantation, histological OL of the tubules have been
noticed retrospectively in kidney transplant recipients when
HES was used for fluid resuscitation of donors with dead
brainstems [11]. However, these lesions had no significant
effect on the occurrence of delayed graft function and serum
creatinine at three and six months post-transplantation. A pro-
spective trial using 6% HES 200/0.62 demonstrated a detri-
mental effect on initial graft function [12]. Accordingly, in our
study the haemodilution with either HES solution directly
before kidney retrieval induced a significant reduction of diure-
sis, Clcrea and sodium transport compared with RL. In another
retrospective study using 6% HES 200/0.5 did not impair
early graft function after kidney transplantation. However, in
the retrospective study less HES was administered [16].
There is only limited data available regarding VRS in an iso-
lated renal perfusion model. The model of isolated porcine
renal perfusion has been used extensively for the investigation
of renal effects of therapeutic interventions [17]. In the study
by Hauet and colleagues, a non-specified HES solution was
compared with NaCl, gelatine and albumin in an isolated, renal
whole blood model over two hours. The authors concluded
from their results that HES induces an osmotic nephrosis [18].
Recently, it was shown that large amounts of 6% HES 200/
0.5 aggravate macrophage's enzyme-release in patients with
impaired renal function possibly resulting in an acquired lyso-
somal storage disease [19].
Interestingly, in our renal perfusion model vacuolisation of
tubular epithelial cell were seen in all groups. They were signif-
icantly more present with the application of 10% HES 200/0.5
and 6% HES 130/0.42 compared with RL. However, there
were also OL in the RL group, thus the question remains
whether these tubular epithelial vacuoles represent renal injury
or might be an epiphenomenon without clinical importance.
The increase of beta-NAG levels in all groups indicated that
tubular injury had occurred. Using RL in our study, diuresis and
Clcrea were significantly higher and beta-NAG levels signifi-
cantly lower comparing with both 10% HES 200/0.5 and 6%
HES 130/0.42. Of note, some differences between 6% HES
130/0.42 and RL had gone after four hours. On histological
investigations we could identify interstitial proliferation, macro-
phage influx and tubular damage as structural alterations of the
Figure 2
N-acetyl-beta-D-glucosamidase in urine as a marker of lysosomal tubu- lar damage N-acetyl-beta-D-glucosamidase in urine as a marker of lysosomal tubu-
lar damage. Data are presented as mean ± standard deviation. Normal 
data are 0 to 7 U/L. * P < 0.05 RL vs. 6% hydroxyethyl starch (HES) 
130/0.42 and 10% HES 200/0.5, § P < 0.001 10% HES 200/0.5 vs. 
Ringer's lactate (RL) and 6% HES 130/0.42. beta-NAG = N-acetyl-
beta-D-glucosamidase.
Figure 3
Values of colloid osmotic pressure over time between the three infusion  groups Values of colloid osmotic pressure over time between the three infusion 
groups. Data are mean ± standard deviation. *P < 0.001 Ringer's lac-
tate (RL) vs. 6% hydroxyethyl starch (HES) 130/0.42 and 10% HES 
200/0.5, + P < 0.05 6% HES 130/0.42 vs. 10% HES 200/0.5.Critical Care    Vol 13 No 1    Hüter et al.
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kidney associated with 10% HES 200/0.5-induced adverse
renal effects. In addition, significant differences between the
two HES solutions with respect to macrophage infiltration
could be identified: interstitial inflammation was more pro-
nounced in 10% HES 200/0.5 than in 6% HES 130/0.42.
Furthermore, interstitial cell proliferation was significantly
higher in 10% HES 200/0.5 than in 6% HES 130/0.42 indi-
cating more pronounced cell activation by 10% HES 200/0.5.
The underlying link between macrophages and HES-induced
renal failure needs to be elucidated further.
Lang and colleagues demonstrated that a high molecular
weight HES preparation (6% HES 670 kD) has no intrinsic
non-thiol-dependent anti-inflammatory properties in vitro indi-
cating that HES preparations may have pro-inflammatory
effects. This phenomenon was not observed with human
serum albumin. The binding of neutrophil-derived myeloperox-
idase to bovine aortic endothelial cells, a mediator of multiple
oxidative and nitric oxide-consuming reactions, was also
enhanced [20]. Increased nitric oxide production through
inducible nitric oxide synthase activity was revealed to induce
decreased expression of tight junction proteins and
decreased tight junction localisation in endotoxaemic mice
[21]. This was associated with gut epithelial barrier dysfunc-
tion evidenced by increased ileal mucosal permeability. On the
other hand, the release of endotoxin in sepsis activates leuco-
cyte-endothelial cell adhesion, capillary leakage and changes
in vascular micro-haemodynamics [22]. Hoffmann and col-
leagues showed a reduction of endotoxin-induced leucocyte-
endothelial cell interaction in endotoxaemic hamsters using
HES 130/0.4, thereby ameliorating endothelial damage [23].
Using a porcine septic shock model, Marx and colleagues
demonstrated attenuation of systemic capillary leakage by
HES 130/0.42 in comparison with HES 200/0.5 [24]. Hence,
there is experimental evidence that different HES solutions
may exert different effects on the inflammatory process.
Major limitations of our study were that we compared an iso-
oncotic 6% HES 130/0.42 solution (in vitro COP 37.8
mmHg) with a hyperoncotic 10% HES 200/0.5 solution (in
vitro  COP 80 to 85 mmHg), thus we cannot differentiate
whether the oncotic force, the molecular weight, the degree of
molar substitution, molecular size or the combination of all or
some factors were determining factors of HES-induced
adverse effects on renal function and structure. Further, the
model used lacks the volume of distribution and the metabo-
lism of a living organism. Other limitations were the small
number of animals per group and the short experimental dura-
tion of ex-vivo perfusion using a centrifugal blood pump pro-
viding non-pulsatile flow. Hence it offers no insights of
potential long term-effects of the investigated VRS.
Conclusions
In conclusion, after haemodilution both HES solutions lead to
a significant decrease in diuresis, Clclea and sodium transport
compared with RL. We identified renal interstitial proliferation,
macrophage infiltration and tubular damage as potential path-
ological mechanisms of HES-induced adverse effects on renal
Table 2
Diuresis, creatinine clearance and sodium transport during isolated renal perfusion over the period of six hours
Time (hours) 0 2 4 6
Diuresis (μl/min/g)
HES 200/0.5 0.6 ± 1.2 0.2 ± 0.3 0.2 ± 0.2b 0.2 ± 0.1b
HES 130/0.42 3.0 ± 1.6 3.9 ± 2.6 3.6 ± 1.6 3.7 ± 1.6
RL 30.4 ± 12.1a 20.2 ± 15.4a 5.0 ± 2.8 9.0 ± 5.6
ClCrea (ml/min/g)
HES 200/0.5 0.01 ± 0.01 0.01 ± 0.01d 0.01 ± 0.01d 0.01 ± 0.01d
HES 130/0.42 0.5 ± 0.07 0.33 ± 0.08 0.13 ± 0.02 0.09 ± 0.01
RL 1.02 ± 0.12c 0.21 ± 0.03 0.12 ± 0.03 0.11 ± 0.05
TrNa (mmol/min/g)
HES 200/0.5 -0.6 ± 0.5 -0.2 ± 0.1 -0.1 ± 0.07b -0.1 ± 0.04b
HES 130/0.42 -3.7 ± 0.9 -3.8 ± 0.8 -4.3 ± 0.7 -4.6 ± 0.7
RL -29.3 ± 5.8c -15.4 ± 6.0d -3.8 ± 1.0 -7.0 ± 6.5
Data are presented as mean ± standard deviation.
a RL vs. 10% HES 200/0.5 and RL vs. 6% HES 130/0.42; P < 0.01
b 10% HES 200/0.5 vs. RL and 10% HES 200/0.5 vs. 6% HES 130/0.42; P < 0.01
c RL vs. 6% HES 130/0.42 and RL vs. 10% HES 200/0.5; P < 0.001
d 10% HES 200/0.5 vs. RL and 10% HES 200/0.5 vs. 6% HES 130/0.42; P < 0.05
ClCrea = creatinine clearance; HES = hydroxyethyl starch; RL = Ringer's lactate; TrNa = sodium transport.Available online http://ccforum.com/content/13/1/R23
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Figure 4
Representative histology sections of proliferating nuclear antigen  stained kidneys Representative histology sections of proliferating nuclear antigen 
stained kidneys. There was statistical less interstitial and glomerular cell 
proliferation in (b) 6% hydroxyethyl starch (HES) 130/0.42 compared 
with (a) 10% HES 200/0.5 and (c) Ringer's lactate (RL). Original mag-
nification: × 200. PCNA = proliferating nuclear antigen.
Figure 5
Representative findings of immunohistological staining of ED-1 positive  interstitial macrophages Representative findings of immunohistological staining of ED-1 positive 
interstitial macrophages. There was a significant higher number of infil-
trating macrophages and also of other inflammatory cells in (a) 10% 
hydroxyethyl starch (HES) 200/0.5 compared with (b) 6% HES 130/
0.42 and (c) Ringer's lactate (RL). Original magnification: × 200. ED-1 
= marker for macrophage infiltration.Critical Care    Vol 13 No 1    Hüter et al.
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function using an isolated porcine renal perfusion model. Fur-
thermore, we demonstrated that 10% HES 200/0.5 had more
of a pro-inflammatory effect compared with 6% HES 130/0.42
and caused more pronounced tubular damage than 6% HES
130/0.42 and RL.
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